Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 97

 

Home  | About Us | Editors | Search | Ahead Of Print | Current Issue | Archives | Submit Article | Instructions | Subscribe | Contacts | Login 
     
CASE REPORT
Year : 2020  |  Volume : 10  |  Issue : 4  |  Page : 216-219

Use of CytoSorb® as a therapeutic option in a critically ill patient with acute respiratory distress syndrome caused by influenza A (H1N1) pneumonia: A case report


1 Medical Intensive Care Unit, University Clinical Center of Republic of Srpska; Department of Medical Intensive Care Unit, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina
2 Medical Intensive Care Unit, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina
3 Department of Medical Intensive Care Unit, Faculty of Medicine, University of Banja Luka; Department of Pharmacy, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina

Correspondence Address:
Prof. Pedja Kovacevic
Filipa Kljajica Fice 49, 78000, Banja Luka
Bosnia and Herzegovina
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/IJCIIS.IJCIIS_56_20

Rights and Permissions

Acute respiratory distress syndrome is an acute inflammatory lung process, which leads to protein-rich nonhydrostatic pulmonary edema, refractory hypoxemia, and lung “stiffness”. There are a number of therapies that are currently being investigated in the treatment of sepsis; one of the most promising treatment options at this moment is cytokine removal by hemoperfusion (CytoSorb®). We present the case of a 29-year-old male patient who was admitted to the Medical Intensive Care Unit in a state of multiple organ dysfunction and massive bilateral pneumonia caused by influenza type A. The patient was healthy before hospital admission. Due to acute respiratory failure and altered state of consciousness, the patient was intubated using analgosedation and connected to a controlled mechanical ventilation mode immediately after admission. The initial computed tomography scan showed massive bilateral pneumonia, and few days later, the patient's condition progressively worsened and he developed signs of multiorgan failure. Given the patient's progressing hemodynamic instability and uncontrolled inflammatory response, a CytoSorb® adsorber was added into the continuous renal replacement therapy circuit. The combination of pharmacotherapy, supportive measures, and application of CytoSorb® resulted with complete recovery of the patient (hemodynamic stability improved as evidenced by decreased vasopressor requirements).


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed100    
    Printed0    
    Emailed0    
    PDF Downloaded11    
    Comments [Add]    

Recommend this journal